FIASP PENFILL 5* (Insulin Aspart (100IU/ml))

Fiasp 100 IU/ml Penfill, containing 3 ml in each unit, is utilized for managing blood glucose levels in individuals diagnosed with type 1 or type 2 diabetes. This formulation is a rapid-acting insulin designed to efficiently lower blood sugar levels following meals and to minimize the risk of severe diabetes complications. It is typically prescribed alongside a long-acting insulin or other antidiabetic medications to achieve optimal blood sugar control. Administration of this medication should occur just before or within 20 minutes after commencing a meal, and it is crucial for patients to learn the proper subcutaneous injection techniques, as instructed by a healthcare professional. Regular monitoring of blood glucose is essential for understanding how the medication affects an individual’s levels and for determining the appropriate dosage. Patients should refrain from using this medication during episodes of hypoglycemia, or low blood sugar. Prior to initiating treatment, it is advisable for individuals to inform their healthcare provider of any prior kidney, liver, or heart issues. Pregnant or breastfeeding individuals should also seek medical advice regarding dosage adjustments. It is important to continue this medication only under medical guidance and as part of a comprehensive treatment strategy that includes dietary management, physical activity, and weight control as per healthcare recommendations.